Added to YB: 2026-02-02
Pitch date: 2026-01-30
ERF.PA [neutral]
Eurofins Scientific SE
-1.4%
current return
Author Info
Colubeat Investment Desk writes and shares analysis on exceptional companies with sustainable moats. Sometimes undervalued, always high quality. Sign up for the newsletter.
Company Info
Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide.
Market Cap
EUR 12.0B
Pitch Price
EUR 68.38
Price Target
N/A
Dividend
1.06%
EV/EBITDA
10.41
P/E
30.42
EV/Sales
2.15
Sector
Life Sciences Tools and Services
Category
value
Update: Eurofins Scientific ($ERF) FY 2025 Results
ERF.PA (earnings): 2025 results validate thesis - organic growth accelerated to 4.7% in Q4, EBITDA margin +70bps to 21.4%, CAPEX intensity down to 4.5% vs 5.2%, FCF +9% to €876m. US ops at 27.9% margins show potential as hub-spoke model scales. CEO calls stock 'no-brainer' at 10x EBITDA vs private market 18-20x.
Read full article (6 min)